MYLAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK &...
NEW ORLEANS, Dec. 02, 2016 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
View ArticleDEADLINE ALERT: Brower Piven Notifies Shareholders of Upcoming Deadline In...
STEVENSON, Md., Dec. 08, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United...
View ArticleMomenta and Mylan Report Initial Results from Phase 1 Clinical Trial for...
CAMBRIDGE, Mass. and HERTFORDSHIRE, United Kingdom and PITTSBURGH, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Mylan N.V. (NASDAQ:MYL) (TASE:MYL), today announced...
View ArticleNew Research Coverage Highlights Mylan, Genworth Financial, Chevron, Southern...
NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...
View ArticleMarket Trends Toward New Normal in Patterson-UTI Energy, SAExploration, vTv...
NEW YORK, Dec. 04, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...
View ArticleMomenta and Mylan Announce Development Strategy for M710, a Proposed...
CAMBRIDGE, Mass., HERTFORDSHIRE, United Kingdom and PITTSBURGH, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) and Mylan N.V. (NASDAQ:MYL) (TASE:MYL) today announced the...
View ArticleDetailed Research: Economic Perspectives on OUTFRONT Media, Mylan N.V,...
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...
View ArticleFactors of Influence in 2018, Key Indicators and Opportunity within Regency...
NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and...
View ArticleReport: Developing Opportunities within Sunoco LP, Mylan N.V., Ares...
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
View ArticleMapi Pharma Presents Phase II Extension Results of Glatiramer Acetate Depot...
81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 yearsGA Depot Has Potential to Address Multiple Sclerosis Treatment Burden and Improve Patient ComplianceNESS ZIONA,...
View ArticleConsolidated Research: 2018 Summary Expectations for Green Brick Partners,...
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders,...
View ArticleMarket Trends Toward New Normal in Hasbro, Spark Energy, QUALCOMM, Green...
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
View ArticleMapi Pharma to Host Key Opinion Leader Meeting on Long Acting Glatiramer...
NESS ZIONA, Israel, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical late stage biopharmaceutical company, announced today that it will host a Key Opinion Leader (KOL)...
View ArticleNew Research: Key Drivers of Growth for Toll Brothers, Mylan N.V, Eldorado...
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders,...
View ArticleMapi Pharma Receives Government of Israel Funding for the Establishment of a...
NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, announced today that it has received complementary funding...
View ArticleMedexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele...
MONTREAL, June 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), a leading specialty pharmaceutical company with a strong North American...
View ArticleMapi Pharma to Build a New Sterile Injectable Production Plant for GA Depot...
NESS ZIONA, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company announced today that is has signed a long term...
View ArticleMapi Pharma to Present Series of Recent Advancements for Treating Multiple...
Results for Glatiramer Acetate (GA) Depot 3 year analysis in RRMS, GA Depot safety results in RRMS and PPMS, and novel anti-BMP for remyelination will be presentedECTRIMS 2019 to be held in Helsinki,...
View Article
More Pages to Explore .....